Vol. 19/No. 14 | OncologyLive

Wolmark's Passion for Evidence-Based Medicine Helped Transform Cancer Care

July 30, 2018

Norman Wolmark, MD, a 2017 Giants of Cancer Care® award winner in the Breast Cancer category, played a pivotal role in building the clinical trials program at the National Surgical Adjuvant Breast and Bowel Project.

Agent That Starves Tumor Cells May Improve Survival in Metastatic RCC

July 24, 2018

A novel glutaminase inhibitor CB-839, may provide a survival benefit in combination with cabozantinib (Cabometyx) by cutting off the energy supply to tumor cells in patients with metastatic renal cell carcinoma.

The Rising Incidence of Early-Onset CRC: What Do We Know and What Can We Do?

July 24, 2018

During an OncLive Peer Exchange® program on individualizing treatment and improving outcomes for patients with CRC, a panel of experts shared their insights on early-onset CRC, which has been observed to occur as early as adolescence.

Palliative Thoracic EBRT With Concurrent Chemotherapy Is an Option for Incurable NSCLC

July 23, 2018

A review of available evidence has led the American Society for Radiation Oncology to issue a strong recommendation for use of concurrent chemotherapy with thoracic external beam radiation therapy in a subset of patients with incurable stage III non–small cell lung cancer.

Developing Best Practices to Mitigate Opioid Abuse Is a Priority in Cancer Care

July 23, 2018

Opioids are prescribed to manage cancer pain because the benefits generally outweigh the risks and because of the ethical imperative for quick relief. However, patients are exposed to a degree of risk for misuse and abuse.

West Coast Study Rates Cancer Centers by Cost and Quality

July 17, 2018

In a groundbreaking study of costs and quality of cancer care among cancer clinics in the state of Washington, investigators found wide disparity in end-of-life care, suggesting that improvements in cost and quality could be attained if treatment centers share information on what works and endeavor to improve.